What is National Research Debt-to-Equity?
National Research's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $6.5 Mil. National Research's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $58.7 Mil. National Research's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $29.7 Mil.
National Research's debt to equity for the quarter that ended in Mar. 2025 was 2.20.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for National Research's Debt-to-Equity or its related term are showing as below:
NRC'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.37 Max: 2.2
Current: 2.2
During the past 13 years, the highest Debt-to-Equity Ratio of National Research was 2.20. The lowest was 0.00. And the median was 0.37.
National Research Debt-to-Equity Historical Data
The historical data trend for National Research's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Research Debt-to-Equity Chart
|
National Research Annual Data
|
|
Trend |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
Dec24 |
| Debt-to-Equity |
|
Get a 7-Day Free Trial
|
|
|
0.48 |
0.31 |
0.31 |
0.75 |
2.00 |
|
National Research Quarterly Data
|
|
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
Dec24 |
Mar25 |
| Debt-to-Equity |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
1.14 |
1.05 |
1.55 |
2.00 |
2.20 |
Competitive Comparison of National Research's Debt-to-Equity
For the Health Information Services subindustry, National Research's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Research's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Research's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where National Research's Debt-to-Equity falls into.
National Research Debt-to-Equity Calculation
Debt to Equity measures the financial leverage a company has.
National Research's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as
National Research's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Research Business Description
Traded in Other Exchanges
N/A
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
| Patrick E Beans |
director, officer: CFO and Secretary |
AMANDLA LLC, 709 PIER 2, LINCOLN NE 68528 |
| Amandla Mk Trust |
10 percent owner |
C/O THE BRYN MAWR TRUST COMPANY OF DELAW, 20 MONTCHANIN RD, SUITE 100, GREENVILLE DE 19807 |
| Common Property Trust |
10 percent owner |
709 PIER 2, LINCOLN NE 68528 |
| Parul Bhandari |
director |
1775 I STREET NW, SUITE 910, WASHINGTON DC 20006 |
| Penny Ann Wheeler |
director |
C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508 |
| Stephen H Lockhart |
director |
C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508 |
| Donald M Berwick |
director |
C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508 |
| Jona S Raasch |
officer: Vice President and COO |
|
| Kevin R Karas |
officer: SVP Finance, CFO, Treas & Secy |
C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508 |
| Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 |
10 percent owner |
C/O BESSEMER TRUST COMPANY OF DELAWARE, 1007 N. ORANGE ST., SUITE 1450, WILMINGTON DE 19801 |
| Joann M Martin |
director |
6221 ANDREW COURT, LINCOLN NE 68512 |
| Helen Hrdy |
officer: Chief Growth Officer |
C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508 |
| Steven D. Jackson |
officer: President |
C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508 |
| John N Nunnelly |
director |
P.O. BOX 2175, AMHERST MA 01004 |
| Barbara Mowry |
director |
P.O. BOX 103115, DENVER CO 80250 |
National Research Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NRC has been successfully added to your